Sixth Immunotherapy of Cancer conference (ITOC): advances and perspectives-a meeting report

J Immunother Cancer. 2020 Feb;8(1):e000268. doi: 10.1136/jitc-2019-000268.

Abstract

Immunotherapy has moved to the forefront of cancer treatment, illustrated by the accelerating pace of novel therapy approvals. In this complex environment, scientists rely on cutting edge conferences to stay informed. The Immunotherapy of Cancer (ITOC) conference was established jointly with the Society of the Immunotherapy of Cancer to bring the European researchers together. In its sixth edition, the ITOC conference has recently been held in Vienna, Austria.

Keywords: immunology; tumours.

Publication types

  • Research Support, Non-U.S. Gov't